Vident Investment Advisory’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,303	Closed	-$498K	–	1088
2023 Q2	$498K	Sell	1,303 -453	-26%	-$162K	0.02%	699
2023 Q1	$608K	Buy	1,756 +351	+25%	+$103K	0.02%	702
2022 Q4	$331K	Buy	+1,405	New	+$333K	0.01%	853
2022 Q3	–	Sell	-883	Closed	-$271K	–	1349
2022 Q2	$271K	Sell	883 -1,055	-54%	-$343K	0.01%	1051
2022 Q1	$795K	Sell	1,938 -1,620	-46%	-$634K	0.02%	785
2021 Q4	$1.67M	Sell	3,558 -416	-10%	-$179K	0.04%	529
2021 Q3	$1.69M	Sell	3,974 -2,188	-36%	-$922K	0.05%	507
2021 Q2	$2.21M	Buy	6,162 +2,231	+57%	+$737K	0.07%	367
2021 Q1	$1.11M	Buy	3,931 +1,162	+42%	+$333K	0.04%	586
2020 Q4	$784K	Buy	2,769 +40	+1%	+$11.2K	0.03%	599
2020 Q3	$750K	Sell	2,729 -626	-19%	-$166K	0.04%	569
2020 Q2	$762K	Buy	3,355 +430	+15%	+$84.5K	0.04%	552
2020 Q1	$445K	Buy	+2,925	New	+$450K	0.03%	599
2015 Q3	–	Sell	-11,194	Closed	-$650K	–	1160
2015 Q2	$650K	Buy	11,194 +411	+4%	+$22.9K	0.09%	333
2015 Q1	$649K	Sell	10,783 -1,550	-13%	-$82.6K	0.13%	243
2014 Q4	$657K	Buy	+12,333	New	+$617K	0.22%	136